Pharmaplan (TTP Group) | New office in Visp close to Lonza
Share this article
New office with 60 employees
In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another office in Switzerland in the third quarter of 2021. With the new subsidiary at the biotech site in Visp, Pharmaplan as Swiss market leader, is meeting the growing global demand for pharmaceutical engineering services and is also underlining its engagement in the region.
The objective is to handle the projects of regional customers in all phases from planning, realisation, and qualification to handover to the operational users, and hence to strengthen customer relationships in the Valais, such as with Lonza AG. “Visp is an important hub for biotechnological pharmaceutical production and we are pleased to now work even closer with the global player, Lonza AG in Valais. With the new subsidiary, we are also making our promise come true. As a strategic partner and single point of contact, our project teams guarantee to our customers flexible project execution on site for construction, commissioning and qualification of their pharmaceutical and biotech production plants,” says Stefan Berg, Managing Director of Pharmaplan AG in Switzerland.